Effects on virological and immunological parameters during CD34 mobilization in HIV patients with lymphoma

American Journal of Hematology

Volumn 81, Issue 10, 2006, Pages 800-802

  Bortolin, Maria Teresa ^a   Simonelli, Cecilia ^a   Zanussi, Stefania ^a   Pratesi, Chiara ^a   Bidoli, Ettore ^a   Rupolo, Maurizio ^a   Berretta, Massimiliano ^a   Tedeschi, Rosamaria ^a   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

ASCT; CD4; CD8; G CSF; HIV load; Lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT; CD34 ANTIGEN; CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; METHYLPREDNISOLONE; MITOXANTRONE; OXALIPLATIN; RITUXIMAB; VIRUS DNA; VIRUS RNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; PRIORITY JOURNAL; VIROLOGY;

ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CD4-CD8 RATIO; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; MIDDLE AGED; PROVIRUSES; RECURRENCE; RNA, VIRAL; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 33749352563     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20610     Document Type: Article

References (9)

1. Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J, et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood 2001;98:3857-3859.
2. Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003;21:4423-4427.
3. Simonelli C, Michieli M. Autologous stem cell transplantation for HIV-infected individuals with relapsed lymphomas. No longer an experimental strategy. Blood 2005;105:439-440.
4. Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y, et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 2004;89:1100-1108.
5. Law P, Lane TA, Gervaix A, Looney D, Schwarz L, Young D, et al. Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals. Exp Hematol 1999;27:147-154.
6. Campbell TB, Sevin A, Coombs RW, Peterson GC, Rosandich M, Kuritzkes DR, et al. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team. Blood 2000;95:48-55.
7. Baillou C, Simon A, Leclercq V, Azar N, Rosenzwajg M, Herson S, et al. Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy. AIDS 2003;17:563-574.
8. O'Doherty U, Swiggard WJ, Jeyakumar D, McGain D, Malim MH. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J Virol 2002;76:10942-10950.
9. Campbell TB, Rapaport E, Schooley RT, Kuritzkes DR. Increased replication of HIV-1 minor variants during hematopoietic stem-cell mobilization with filgrastim. J Infect Dis 2004;190:257-266.